Evaluation of the Effect of Music Medicine Application on Menstrual Symptoms

NCT ID: NCT06314165

Last Updated: 2024-03-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

62 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-03-10

Study Completion Date

2025-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In this study, the "Music Medicine Application" method was chosen in line with the literature and guidelines and it is aimed to determine whether it is effective in reducing the symptoms experienced by female students with "Music Medicine Application" during the menstrual period.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study aims to determine whether the application of music medicine is effective in reducing the symptoms experienced by female students during the menstrual period. The type of research was planned as a prospective, randomized controlled experimental study with a pretest-posttest control group. The research will be conducted with female students studying at Pamukkale University Faculty of Health Sciences. The data of the research will be collected between March 2024 and February 2025. Personal Information Form, Visual Analogue Scale and Menstruation Symptom Scale will be used to collect data. It was determined that a total of 62 people should participate in the research, 31 in the experimental group and 31 in the control group. As the randomization method, "simple randomization" will be used to ensure an equal number of samples in the experimental and control groups. Randomization will be done using the www.randomizer.org application. The data will be analyzed using the SPSS (23.0) package program. Continuous variables will be given as mean ± standard deviation and categorical variables will be given as number and percentage. Significance Test of Difference Between Two Means in comparing independent group differences when parametric test assumptions are met; When parametric test assumptions are not met, Mann-Whitney U test will be used to compare independent group differences.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Menstruation; Syndrome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Two groups: comparative experiment and control
Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

SINGLE

Participants
Participants included in the study will not know which group they are in. In this way, the study will be carried out in a single-blind manner.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

group practicing music medicine

There will be 2 follow-ups for each group. In the first follow-up for the experimental group, when symptoms begin on the first day of their menstrual period, they will be asked to fill out the Menstruation Symptom Scale and Visual Analogue Scale, and the designated music will be played for 30 minutes. After 30 minutes, he/she will be asked to fill out the same surveys again. In the 2nd follow-up (during the menstrual period one month after the first follow-up), they will be asked to repeat what was done in the 1st follow-up on the first day of their menstrual period.

Group Type EXPERIMENTAL

music medicine practice

Intervention Type OTHER

Music medicine will be applied

Group where music medicine is not applied

Two follow-ups will be applied to the groups. At the first follow-up for the control group, they will be asked to fill out the Menstruation Symptom Scale and Visual Analog Scale when symptoms begin on the first day of their menstrual period. In the 2nd follow-up (during the menstrual period one month after the first follow-up), they will be asked to repeat what was done in the 1st follow-up on the first day of their menstrual period.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

music medicine practice

Music medicine will be applied

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Volunteering to participate in the research
2. Menstrual cycle length has been within normal limits (21-35) for the last 3 months
3. Not using oral contraceptives for the last 3 months
4. Not having any psychiatric problems and not receiving any treatment for this in the last 3 months.
5. Not using painkillers or any pharmacological agents or methods that reduce symptoms during the study.
6. Participants who marked 1.1-10 according to Visüel analog scala

Exclusion Criteria

1. Presence of chronic diseases or serious medical conditions
2. Presence of another physical or psychological disorder that may affect menstrual symptoms
3. Presence of psychiatric or psychological disorders
4. Active drug use or hormone therapy
5. Having given birth
6. Answering survey questions incompletely or not answering them
7. Participants who marked 0-1 according to Visüel analog scala
8. Not applying music medicine for the experimental group
Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Pamukkale University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Sevgi Özkan

Professor Doctor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Sevgi Özkan Professor Doctor

Role: PRINCIPAL_INVESTIGATOR

Pamukkale University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Pamukkale University Faculty of Health Sciences

Denizli, , Turkey (Türkiye)

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Rabia Nur Doğan

Role: CONTACT

+905528400797

Sevgi Özkan Professor Doctor

Role: CONTACT

+905336125588

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Rabia Nur Doğan

Role: primary

+905528400797

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

PamukkaleU-SBE-RND-01

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.